Interestingly, our results show a positive correlation between CD45 mRNA expression and outcomes, but we also found a negative correlation between the frequency of CD45-positive cells and OS in a different patient cohort when analyzing all breast cancers together. This evidence concerns the gene PTPRC and breast carcinoma.